Accomplished executive with more than three years of experience in regulatory affairs. Expertise includes regulatory filings, compliance, NDA/ANDA submissions, and deficiency responses. Proven track record in enhancing processes and consistently meeting deadlines, contributing to organizational efficiency. Aspiring to leverage regulatory expertise to foster company growth while pursuing personal professional development.
1. 505(b)(2) NDA Labeling.
2. ANDA Labeling/Complex Generics.
3. Labeling Deficiencies.
4. Exhibit Batches Artworks and Threshold Analysis
5. Post-Approval Labeling
DESIGN, OPTIMIZATION, AND EVALUATION OF PULSATILE RELEASE TABLET OF AMBRISENTAN
Novel Approach to Pulsatile Drug Delivery System: An Updated Review
International Journal of All Research, Education, & Scientific Methods (IJARESM), ISSN No: 2455-6211, Impact Factor: 7.429
All what is stated in the CV are true and factual.
Ashu Jawla